AI English summary of an SEC filing — figures as filed
The company said Mr. Gerald Storch notified its Board of Directors on March 13, 2024 that he will not stand for re-election to the Board at the 2024 Annual Meeting of Shareholders.
Key points
AI summaryThe company said Mr. Gerald Storch notified its Board of Directors on March 13, 2024 that he will not stand for re-election to the Board at the 2024 Annual Meeting of Shareholders.
The company said the Board set the number of directors at ten, effective immediately after the 2024 Annual Meeting of Shareholders.
The company said in the filing that the 2024 Annual Meeting of Shareholders is expected to be held on May 7, 2024.
Bristol-Myers Squibb filed this Form 8-K under Item 5.02, which covers changes in directors and certain officers. The date of the earliest event reported is March 13, 2024, and the signing date is March 18, 2024.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Gerald Storch Won't Seek Re-Election to Board
The company said Mr. Gerald Storch notified its Board of Directors on March 13, 2024 that he will not stand for re-election to the Board at the 2024 Annual Meeting of Shareholders.
Source · Based on the filing body and exhibits
Board Sets Number of Directors
The company said the Board set the number of directors at ten, effective immediately after the 2024 Annual Meeting of Shareholders.
Source · Based on the filing body and exhibits
2024 Annual Meeting Expected Date
The company said in the filing that the 2024 Annual Meeting of Shareholders is expected to be held on May 7, 2024.
Source · Based on the filing body and exhibits
Form 8-K Item 5.02 Report on Officer and Director Changes
Bristol-Myers Squibb filed this Form 8-K under Item 5.02, which covers changes in directors and certain officers. The date of the earliest event reported is March 13, 2024, and the signing date is March 18, 2024.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…